Clinical Observations, Plasma Retinol Concentrations, and In Vitro Lymphocyte Functions in Children With Sickle Cell

Solo R Kuvibidila1, Renée Gardner1, Maria Velez1

  • 1Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA.

Ochsner Journal
|December 19, 2018
PubMed

Insights

Children with sickle cell disease (SCD) may have suboptimal vitamin A levels, impacting their immune function and health. Addressing vitamin A deficiency could improve immunity and reduce complications in these children.

Area of Science:

  • Pediatric Hematology
  • Nutritional Immunology
  • Biochemistry

Background:

  • Children with sickle cell disease (SCD) exhibit increased susceptibility to infections, growth deficits, and impaired immunity.
  • These health issues mirror those seen in individuals with vitamin A deficiency, characterized by low plasma retinol concentrations (<20 μg/dL).

Purpose of the Study:

  • To investigate the association between vitamin A status, overall health, and in vitro immune function in children with SCD.

Main Methods:

  • Plasma retinol, retinol binding protein, C-reactive protein, and alpha-1-acid glycoprotein levels were measured in 59 children with SCD (ages 9 months to 18 years).
  • In vitro immune function was assessed by measuring lymphocyte proliferation and interleukin-2 (IL-2) activity.
  • Participants included children with SS, SC, and Sβthalassemia hemoglobin genotypes.

Main Results:

  • Plasma retinol concentrations in children with SCD were comparable to those in healthy individuals but were lower in boys than girls and in children with inflammation.
  • Seven children (11.9%) were vitamin A-deficient, and 9 (15.3%) had suboptimal vitamin A status.
  • Children with vitamin A deficiency showed trends toward lower height and weight percentiles, reduced lymphocyte proliferation, and IL-2 activity, alongside higher C-reactive protein levels, pain crisis episodes, and inflammation.

Conclusions:

  • Suboptimal vitamin A status is present in a significant proportion of children with SCD.
  • Identification and correction of vitamin A deficiency may enhance immune responses.
  • Improving vitamin A status holds potential for attenuating health complications associated with SCD.
Abstract

Related Concept Videos

Concentration Cells02:41

Concentration Cells

A concentration cell is a type of a  voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:
25.9K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
650
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
942
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
586
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
430